| #104 |
Johannes Wirenfeldt Vad Pedersen |
Go Therapeutics |
1 |
| #104 |
Anders Robert JELLINGGAARD |
3Shape A/S |
1 |
| #104 |
Christian Berg Oehlenschlaeger |
Novozymes A/S |
1 |
| #104 |
Esben GRUNDTVIG |
Svitzer A/S |
1 |
| #104 |
Enrico Fratesi |
Dedon Gmbh |
1 |
| #104 |
Esben Halkjaer Hansen |
Evolva Sa |
1 |
| #104 |
Louise Buur |
H. Lundbeck A/S |
1 |
| #104 |
Josefine Nielsen Søderberg |
H. Lundbeck A/S |
1 |
| #104 |
Marc Dominique Morant |
Novozymes A/S |
1 |
| #104 |
Johannes Beil |
Palantir Technologies |
1 |
| #104 |
Peter Morten Moselund |
Nkt Photonics A/S |
1 |
| #104 |
Laurids Egedal Kirchhoff |
Gn Hearing A/S |
1 |
| #104 |
Søren Christian Voigt Pedersen |
— |
1 |
| #104 |
Adam Matthew Takos |
Snipr Biome Aps |
1 |
| #104 |
Christopher James Lüscher |
— |
1 |
| #104 |
Lars Henriksen |
Modl.Ai Aps |
1 |
| #104 |
Jakob Konradsen |
— |
1 |
| #104 |
Christian Herschend Jacobsen |
— |
1 |
| #104 |
Jens Henrik Steffens |
Gn Hearing A/S |
1 |
| #104 |
Sigurd Jervelund Hansen |
— |
1 |
| #104 |
Theo Fischer Ginman |
— |
1 |
| #104 |
Henrik Kofoed Munch |
Zealand Pharma A/S |
1 |
| #104 |
Daniele Granata |
Novo Nordisk A/S |
1 |
| #104 |
Rune Salbo |
Novo Nordisk A/S |
1 |